Summary
- Current Price
- As of today, HIMS price is $23.75, down -1.08% on
- Current Price All-Time High
- HIMS price is currently -67.46% below its historical high of $72.98 set on
- Market Cap
- HIMS current market cap is $5B, down -54.11% year-over-year
- PE Ratio
- HIMS PE ratio is unknown
- Revenue
- HIMS current annual revenue is $2.35B, up +59.00% year-over-year
- Next Earnings
- The next earnings release for HIMS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Hims & Hers Health, Inc. |
| Ticker | NYSE: HIMS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hims.com |
| Employees | 1,637 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $23.75 | |
| Price, 1D Change | -1.08% | |
| Market Cap | $5B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.39 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +59.00% | |
| EPS | $0.51 | |
| EPS, 1Y Change | -3.74% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | OAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.51 | |
| EPS Estimate | N/A | -$0.12 |
| EPS Est. Change | N/A | -124.05% |
| Revenue | $2.35B | |
| Revenue Estimate | N/A | $2.88B |
| Revenue Est. Change | N/A | +22.69% |
| Current Price | $23.75 | |
| Price Target | - | $25.00 |
| Price Tgt. Change | - | +5.26% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.85 | $0.53 | -37.20% | |
| $0.47 | $0.51 | +8.95% | |
| -$0.12 | N/A | -124.05% | |
| $0.52 | N/A | +0.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.46B | $1.48B | +0.92% | |
| $2.35B | $2.35B | +0.03% | |
| $2.88B | N/A | +22.69% | |
| $3.38B | N/A | +43.79% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -55.62% | |
| Price, 3Y | +150.00% | |
| Market Cap, 1Y | -54.11% | |
| Market Cap, 3Y | +176.44% | |
| Revenue, 1Y | +59.00% | |
| Revenue, 3Y | +345.54% | |
| EPS, 1Y | -3.74% | |
| EPS, 3Y | +259.55% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $23.75 | |
| SMA 200 | $34.94 | |
| SMA 200 vs Price | +47.10% | |
| SMA 50 | $24.25 | |
| SMA 50 vs Price | +2.11% | |
| Beta | 2.39 | |
| ATR | $1.96 | |
| 14-Day RSI | 46.06 | |
| 10-Day Volatility | 99.92% | |
| 1-Year Volatility | 96.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.35B | |
| EPS | $0.51 | |
| Gross Profit | $1.39B | |
| Gross Margin | 59.31% | |
| Operating Profit | $121.69M | |
| Operating Margin | 5.18% | |
| Net Income | $128.37M | |
| Net Margin | 5.47% | |
| EBITDA | $176.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.07 | |
| 1.90 | ||
| 1.61 | ||
| - | ||
| 3 | ||
| 3.45 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 2.32 | ||
| 12.32 | ||
| 50.90 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $540.93M | |
| $577.49M | ||
| $2.15B | ||
| $767.64M | ||
| $1.61B | ||
| $404.43M | ||
| Total Debt | $1.12B | |
| $4.84M | ||
| $143.28M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.22B | ||
| $1.27B | ||
| $955.21M | ||
| $0.00 | ||
| $54.50M | ||
| $0.00 | ||
| -$4.44M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $300.01M | ||
| -$1.02B | ||
| $729.62M | ||
| Capex | $242.59M | |
| $57.42M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| B of A Securities | → | |
| B of A Securities | → | |
| Needham | → | |
| JP Morgan | → | |
| Citigroup | → | |
| BTIG | → | |
| JP Morgan | ||
| B of A Securities | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with HIMS
FAQ
What is the ticker symbol for Hims & Hers Health, Inc.?
The ticker symbol for Hims & Hers Health, Inc. is NYSE:HIMS
Does Hims & Hers Health, Inc. pay dividends?
No, Hims & Hers Health, Inc. does not pay dividends
What sector is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is in the Healthcare sector
What industry is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Hims & Hers Health, Inc. based in?
Hims & Hers Health, Inc. is headquartered in United States
When did Hims & Hers Health, Inc. go public?
Hims & Hers Health, Inc. initial public offering (IPO) was on September 13, 2019
Is Hims & Hers Health, Inc. in the S&P 500?
No, Hims & Hers Health, Inc. is not included in the S&P 500 index
Is Hims & Hers Health, Inc. in the NASDAQ 100?
No, Hims & Hers Health, Inc. is not included in the NASDAQ 100 index
Is Hims & Hers Health, Inc. in the Dow Jones?
No, Hims & Hers Health, Inc. is not included in the Dow Jones index
When was Hims & Hers Health, Inc. last earnings report?
Hims & Hers Health, Inc.'s most recent earnings report was on May 11, 2026
When does Hims & Hers Health, Inc. report earnings?
The next expected earnings date for Hims & Hers Health, Inc. is August 10, 2026
Data Sources & References
- HIMS Official Website www.hims.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1773751/000177375126000022/0001773751-26-000022-index.htm
- HIMS Profile on Yahoo Finance finance.yahoo.com/quote/HIMS
- HIMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hims